SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA, HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Last-Resort drug shows promise for tough head and neck cancers
Disease control CompletedThis study tested a chemotherapy drug called mitomycin C in 48 adults with advanced head and neck cancer that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors. The trial focused on two groups: patients with HPV-related tonsil/base…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Immunotherapy shows promise in shrinking head and neck tumors before surgery
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab (MK-3475) before standard surgery could help prevent head and neck cancer from coming back. It included 67 adults with advanced, surgically removable head and neck cancer. The main goal was to see if the drug c…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:02 UTC